Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients (Q42990500)

12 November 2017

title

Expression of interferon alpha/beta receptor in the liver of chronic hepatitis C patients (English)

1 reference

12 November 2017

1 reference

1 reference

Mizukoshi E

1

1 reference

12 November 2017

Kaneko S

2

1 reference

12 November 2017

Yanagi M

3

1 reference

12 November 2017

Ohno H

4

1 reference

12 November 2017

Kaji K

5

1 reference

12 November 2017

Terasaki S

6

1 reference

12 November 2017

Shimoda A

7

1 reference

12 November 2017

Matsushita E

8

1 reference

12 November 2017

Kobayashi K

9

1 reference

12 November 2017

publication date

1 November 1998

1 reference

Journal of Medical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

56

1 reference

12 November 2017

issue

3

1 reference

12 November 2017

page(s)

217-223

1 reference

Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Serum levels of interferon-α and-γ in acute and chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons alpha and gamma and double-stranded RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Effectiveness of interferon-alpha therapy in chronic hepatitis C is associated with the amount of interferon-alpha receptor mRNA in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Influence of viral quasispecies on effectiveness of interferon therapy in chronic hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Regulation of interferon receptor expression in human blood lymphocytes in vitro and during interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

The human interferon alpha/beta receptor: characterization and molecular cloning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Chromosome banding, isoenzyme studies and determination of epstein-barr virus DNA content on human burkitt lymphoma/mouse hybrids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Genetic transfer of a functional human interferon alpha receptor into mouse cells: cloning and expression of its cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Alpha and beta interferons and their receptor and their friends and relations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Quantitative analysis of interferon alpha/beta receptor mRNA in the liver of patients with chronic hepatitis C: correlation with serum hepatitis C virus-RNA levels and response to treatment with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Studies of the interferon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Quantitation of changes in the expression of multiple genes by simultaneous polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Clearance of serum hepatitis C virus RNA after interferon therapy in relation to virus genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Changes in interferon receptors on peripheral blood mononuclear cells from patients with chronic hepatitis B being treated with interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

Predictive factors in the response to interferon therapy in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199811%2956%3A3%3C217%3A%3AAID-JMV7%3E3.0.CO%3B2-A

10.1002/(SICI)1096-9071(199811)56:3<217::AID-JMV7>3.0.CO;2-A

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference